CorMedix, Inc. (CRMD):企業概要、財務及び戦略的SWOT分析

◆英語タイトル:CorMedix, Inc. (CRMD) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH137874FSA
◆発行会社(調査会社):GlobalData
◆発行日:2015年1月9日
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD300 ⇒換算¥33,900見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD600 ⇒換算¥67,800見積依頼/購入/質問フォーム
Global Site License(複数国内共有可)USD900 ⇒換算¥101,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary

CorMedix Inc. (CorMedix) is a specialty pharmaceutical company. It develops and commercializes products for prevention and treatment of renal, cardiac, metabolic and infectious diseases. CorMedix enables targeted therapy through its therapeutic candidates such as small molecules, chemical entities, biologics, and devices, among others. Its foundational technology focuses on prevention of infection and clotting caused by the use of chronic central venous catheters (CVCs) in hemodialysis (HD) patients receiving chronic antibiotic therapy, chemotherapy, and intensive care. The company’s licensed products include CRMD003 (Neutrolin), a catheter lock solution that not only prevents of Catheter Related Bloodstream Infections but also maintains catheter patency and CRMD004, a thixotropic gel, in pre-clinical development. CorMedix commercializes its products globally either by out-licensing, partnering, or through its sales force. The company operates in Europe through its subsidiary, CorMedix Europe GmbH, in the area of dialysis services. CorMedix is headquartered in Bridgewater, New Jersey, the US.

CorMedix, Inc. Key Recent Developments

Nov 15, 2013: CorMedix to report third quarter financial results on November 19, 2013
Oct 23, 2013: CorMedix Inc. closes $3,000,000 preferred stock offerings
Oct 18, 2013: CorMedix Inc. to raise $3,000,000 in concurrent offerings
Sep 05, 2013: CorMedix Reports Receipt of European Patent Office Decision to Allow Prosl Patent to Proceed in European Union
Aug 15, 2013: CorMedix Appoints Steven Lefkowitz As Interim CFO

This comprehensive SWOT profile of CorMedix, Inc. provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of CorMedix, Inc. including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

CorMedix, Inc. – Key Information
CorMedix, Inc. – Overview
CorMedix, Inc. – Key Employees
CorMedix, Inc. – Key Employee Biographies
CorMedix, Inc. – Key Operational Heads
CorMedix, Inc. – Major Products and Services
CorMedix, Inc. – History
CorMedix, Inc. – Company Statement
CorMedix, Inc. – Locations And Subsidiaries
CorMedix, Inc. – Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

CorMedix, Inc. – Business Description
CorMedix, Inc. – Corporate Strategy
CorMedix, Inc. – SWOT Analysis
SWOT Analysis – Overview
CorMedix, Inc. – Strengths
CorMedix, Inc. – Weaknesses
CorMedix, Inc. – Opportunities
CorMedix, Inc. – Threats
CorMedix, Inc. – Key Competitors

Section 3 – Company Financial Performance Charts

CorMedix, Inc. – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

CorMedix, Inc., Key Information
CorMedix, Inc., Key Ratios
CorMedix, Inc., Share Data
CorMedix, Inc., Major Products and Services
CorMedix, Inc., History
CorMedix, Inc., Key Employees
CorMedix, Inc., Key Employee Biographies
CorMedix, Inc., Key Operational Heads
CorMedix, Inc., Other Locations
CorMedix, Inc., Subsidiaries
CorMedix, Inc., Key Manufacturing facilities
CorMedix, Inc., Key Competitors
CorMedix, Inc., SWOT Analysis
CorMedix, Inc., Ratios based on current share price
CorMedix, Inc., Annual Ratios
CorMedix, Inc., Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures

CorMedix, Inc., Performance Chart
CorMedix, Inc., Ratio Charts

★海外企業調査レポート[CorMedix, Inc. (CRMD):企業概要、財務及び戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Medivir AB (MVIR B):企業財務及び戦略的SWOT分析
    Summary Medivir AB (Medivir) is a biopharmaceutical company that conducts research and develops new drugs for the treatment of infectious diseases. The company concentrates on research and development in infectious diseases, osteoarthritis, neuropathic pain and oncology. It offers respiratory system …
  • Lakewood-Amedex Inc:企業のM&A・提携動向(医療分野)
    Summary Lakewood-Amedex Inc (Lakewood-Amedex) is a clinical stage biopharmaceutical company that focuses on the development of anti-infective pharmaceuticals. The company develops anti-infective products, including anti-bacterial compounds, gene-silencing anti-virals, locally delivered and orally av …
  • Renata Ltd (RENATA):企業財務及び戦略的SWOT分析
    Summary Renata Ltd (Renata), formerly Pfizer Limited, is a healthcare solution provider that develops and commercializes pharmaceutical and nutritional products for both human and animal use. The company manufactures generic pharmaceutical products including hormones, contraceptives, anti cancer dru …
  • Beida Jade Bird Universal Sci-Tech Ltd. (8095):企業概要、財務及び戦略的SWOT分析
    Summary Beida Jade Bird Universal Sci-Tech Ltd. (Beida Jade Bird) is a supplier of embedded systems. The company promotes the development of domestic high-tech industries. Its products include network security products such as Bluebird Jb-Fw1 gateway firewall, Beida Jade Bird password card Sjy01a, B …
  • iSOFT Group Limited (formerly IBA Health Group Limited):企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' iSOFT Group Limited (formerly I …
  • Northern Oil & Gas, Inc. (NOG):企業のM&A・提携動向(石油・ガス分野)
    Summary Northern Oil & Gas, Inc. (Northern) is an oil and gas company that offers exploration services. The company acquires and maintains properties in Bakken and Three Forks formations within the Williston Basin. It offers services such exploration and production through its non-operating working …
  • KAEL Co., Ltd.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' KAEL Co., Ltd. Mergers and Acqu …
  • Arcapita Bank B.S.C.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Arcapita Bank B.S.C. Mergers an …
  • Sientra Inc (SIEN):企業財務及び戦略的SWOT分析
    Summary Sientra Inc (Sientra) is a medical equipment company that manufactures and markets plastic surgery implantable devices. The company offers products such as body contouring implants, pectoral implants, gluteal implants, oval carving blocks, cosmetic and reconstructive surgery devices includin …
  • GN ReSound AS:企業のM&A・提携動向(医療機器分野)
    Summary GN ReSound A/S (GN ReSound) is a medical equipment company that provides advanced hearing health care solutions. It manufactures advanced technology hearing instruments and solutions for all types of ear-related problems. The company offers hearing aids, accessories and related products. It …
  • MicroPort Scientific Corp (853):企業財務及び戦略的SWOT分析
    Summary MicroPort Scientific Corp (MicroPort) a subsidiary of Otsuka Medical Devices Co., Ltd. is a medical device company that develops, manufactures and markets cardiovascular treatment devices. The company offers products such as cardiovascular devices, orthopedic devices, endovascular devices, e …
  • NanoBio Corp:企業のM&A・提携動向(医療分野)
    Summary NanoBio Corp (NanoBio) is a biopharmaceutical company that develops vaccines. The company develops and commercializes intranasal and intramuscular vaccines for the prevention and treatment of infectious diseases. Its vaccines include anthrax, H5 influenza, pertussis, RSV, HIV, HSV-2, and sea …
  • Turk Prysmian Kablo ve Sistemleri A.S. (PRKAB):企業の財務及び戦略的SWOT分析
    Summary Turk Prysmian Kablo ve Sistemleri A.S. (Turk Prysmian), a subsidiary of Prysmian Group is an energy and telecommunication company that manufactures and markets cables and systems. The company’s products include copper conductor communication cables, fiber optic cables, underground and submar …
  • Avantis Medical Systems Inc-医療機器分野:企業M&A・提携分析
    Summary Avantis Medical Systems Inc (AMS) is a medical device company that provides visualization technology solutions. The company provides products such as single camera colonoscopy devices and third eye panoramic devices. Its third eye panoramic devices provide two side-viewing cameras supplement …
  • Cencosud S.A.:企業概要・SWOT・財務分析
    Summary Canadean's "Cencosud S.A. : Retailing - Company Profile, SWOT and Financial Analysis" contains in depth information and data about the company and its operations. The profile contains a company overview, key facts, major products and services, SWOT analysis, business description, company his …
  • Hormel Foods Corp.の企業概要及び財務/SWOT分析
    Hormel Foods Corp. Fundamental Company Report provides a complete overview of the company’s affairs. The report includes financial and SWOT information, industry analysis, opinions, estimates, Hormel Foods Corp. annual and quarterly forecasts made by stock market experts. The report also enables dir …
  • Zhejiang Yongtai Technology Co Ltd (002326):企業財務及び戦略的SWOT分析
    Summary Zhejiang Yongtai Technology Co Ltd (Yongtai) is a chemical company that manufactures aromatic fluorides. The company’s activities include manufacturing and custom manufacturing services of small fluoro molecules. Its products include fluorinated fluorobenzonitrile, fluorinated nitrobenzene, …
  • THDC India Limited:企業のM&A・提携動向(発電分野)
    Summary THDC India Limited (THDCIL), formerly Tehri Hydro Development Corporation Ltd., is a renewable energy corporation that develops, operates and maintains hydroelectric projects. The corporation develops, operates and maintains hydro power complex and other hydro projects. Its projects include …
  • Axion Power International, Inc. (AXPW):企業のM&A・提携動向(発電分野)
    Summary Axion Power International, Inc. (Axion Power) is an energy equipment manufacturer that designs, develops, manufactures and sells energy storage components and devices. The company offers products like batteries, PowerCube mobile energy storage system and UPS. Its advanced energy storage prod …
  • Intas Pharmaceuticals, Ltd.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Intas Pharmaceuticals, Ltd. Mer …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆